Literature DB >> 3128509

The molecular heterogeneity of nonspecific cross-reacting antigen synthesized by tumor cells and granulocytes.

M Kuroki1, M Kuroki1, G E Moore, S Ichiki, Y Matsuoka.   

Abstract

The molecular heterogeneity of nonspecific cross-reacting antigen (NCA) was examined. Metabolically-labeled glycoproteins were precipitated from cell lysates of human tumor cell lines and of normal peripheral granulocytes with antibodies specific for NCA, and analyzed by SDS-PAGE. NCA components synthesized by three tumor cell lines, QGP-1 (pancreas), HLC-1 (lung) and CAOV-2 (ovary) showed slightly different migration patterns on SDS-PAGE, but the molecular weights of their unglycosylated peptides synthesized in the presence of tunicamycin were all found to be 35K. On the other hand, two molecular species of NCA were identified in normal granulocytes: an 80K mature form derived from a 69K precursor peptide and a 58K mature form from a 41K precursor peptide. Upon SDS-PAGE, the migration pattern of the unglycosylated NCA peptides from tumor cells was affected by the presence of 2-mercaptoethanol, while that of the peptides of granulocytes was not. All the NCAs identified in this study possessed antigenic determinants common to carcinoembryonic antigen as well as those unique to NCA. These results suggest that the molecular heterogeneity of NCA observed thus far resulted from diverse glycosylation of the three fundamental molecular forms of unglycosylated peptides: one with a molecular weight of 35K produced by tumor cells and two with molecular weights of 69K and 41K produced by granulocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128509      PMCID: PMC5907763          DOI: 10.1111/j.1349-7006.1988.tb00014.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family.

Authors:  R J Paxton; G Mooser; H Pande; T D Lee; J E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

2.  Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen.

Authors:  S von Kleist; G Chavanel; P Burtin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

3.  Proceedings: Interrelationship of carcinoembryonic antigen and colon carcinoma antigen-3.

Authors:  E S Newman; S E Petras; A Georgiadis; H J Hansen
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces.

Authors:  M Kuroki; Y Koga; Y Matsuoka
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

6.  Nonspecific cross reacting antigen as a marker for human polymorphs, macrophages and monocytes.

Authors:  P Burtin; P C Quan; M C Sabine
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

7.  Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns.

Authors:  F Grunert; N AbuHarfeil; K Schwarz; S von Kleist
Journal:  Int J Cancer       Date:  1985-09-15       Impact factor: 7.396

8.  The subunit structure of non-specific cross-reacting antigen (NCA).

Authors:  A Krop-Watorek; P Sedlaczek; E Lisowska
Journal:  Mol Immunol       Date:  1983-07       Impact factor: 4.407

9.  Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.

Authors:  M Kuroki; M Kuroki; Y Koga; Y Matsuoka
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

10.  Identification and partial characterization of the unglycosylated peptide of carcinoembryonic antigen synthesized by human tumor cell lines in the presence of tunicamycin.

Authors:  M Kuroki; M Kuroki; S Ichiki; Y Matsuoka
Journal:  Mol Immunol       Date:  1984-08       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.